Rene Holm MSc, PhD

Dr. Rene Holm, Ph.D. received his pharmaceutical training at the Royal Danish School of Pharmacy, now the school of pharmacy at the University of Copenhagen, Denmark, in 1998 and his Ph.D. in biopharmaceutics from the same institution in 2002. Dr. Holm joined Lundbeck in 2001 and changed to Janssen in 2016. Dr. Holm has worked within pharmaceutical development, formulations for non-clinical testing in drug discovery, physical chemistry, and material science covering both small and large molecules and is now responsible for the functional unit ensuring the development of all non-solid formulations for Janssens small molecule value stream. Dr. Holm is (co-) author of more than 140 original articles in peer-reviewed journals and patents in the field of biopharmaceutics and pre-formulation.